Cyrus V Hedvat Selected Research

MART-1 Antigen

9/2003

Melan-A (A103) and inhibin expression in ovarian neoplasms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cyrus V Hedvat Research Topics

Disease

13	Neoplasms (Cancer) 01/2020 - 02/2002
2	Breast Neoplasms (Breast Cancer) 11/2011 - 08/2009
2	Leukemia 03/2010 - 04/2006
2	Multiple Myeloma 01/2006 - 09/2003
2	Carcinoma (Carcinomatosis) 01/2005 - 09/2003
2	Testicular Neoplasms (Testicular Cancer) 01/2005 - 07/2003
2	Plasmacytoma 09/2003 - 07/2003
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2014
1	Lymphoma (Lymphomas) 01/2014
1	Trisomy (Trisomies) 01/2014
1	Glioma (Gliomas) 03/2010
1	Papillary Thyroid Cancer 12/2006
1	Anaplastic Thyroid Carcinoma 12/2006
1	Thyroid Neoplasms (Thyroid Cancer) 12/2006
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2006
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2005
1	Endometrial Neoplasms (Endometrial Cancer) 01/2005
1	Endometrioid Carcinoma 01/2005
1	Hodgkin Disease (Hodgkin's Disease) 09/2004
1	Sclerosis 09/2004
1	Krukenberg Tumor 09/2003
1	Plasma Cell Neoplasms 09/2003
1	Ovarian Neoplasms (Ovarian Cancer) 09/2003
1	Granulosa Cell Tumor 09/2003
1	Melanoma (Melanoma, Malignant) 09/2003
1	Small Cell Carcinoma 09/2003
1	Sertoli-Leydig Cell Tumor 09/2003
1	Luteoma 09/2003
1	Desmoplastic Small Round Cell Tumor 09/2003
1	Neoplasm Metastasis (Metastasis) 12/2002
1	Adenocarcinoma 12/2002
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2002
1	Thymoma (Thymic Carcinoma) 02/2002

Drug/Important Bio-Agent (IBA)

4	Formaldehyde (Formol)FDA Link 11/2013 - 01/2005
4	ParaffinIBA 11/2013 - 01/2005
3	Monoclonal AntibodiesIBA 01/2005 - 02/2002
3	AntigensIBA 01/2005 - 10/2002
2	Proteins (Proteins, Gene)FDA Link 04/2006 - 12/2002
1	Pharmaceutical PreparationsIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 11/2013
1	Cyclin-Dependent Kinase Inhibitor p16IBA 10/2012
1	ChromatinIBA 10/2012
1	Histones (Histone)IBA 10/2012
1	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2012
1	Polycomb-Group ProteinsIBA 10/2012
1	human ERBB2 proteinIBA 11/2011
1	alpha-hydroxyglutarateIBA 03/2010
1	EnzymesIBA 03/2010
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2010
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 03/2010
1	Hormones (Hormone)IBA 08/2009
1	prolinedithiocarbamate (PDTC)IBA 12/2006
1	Retinoic Acid Receptor alphaIBA 04/2006
1	Transcription Factors (Transcription Factor)IBA 04/2006
1	Drug CombinationsIBA 01/2006
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2006
1	Thalidomide (Thalomid)FDA Link 01/2006
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2006
1	NF-kappa B (NF-kB)IBA 09/2004
1	Proto-Oncogene Proteins c-relIBA 09/2004
1	MART-1 AntigenIBA 09/2003
1	erucylphosphocholineIBA 09/2003
1	AntibodiesIBA 09/2003
1	SteroidsIBA 09/2003
1	Inhibins (Inhibin)IBA 09/2003
1	LipidsIBA 09/2003
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2002
1	Biological ProductsIBA 12/2002
1	Protein Isoforms (Isoforms)IBA 02/2002

Therapy/Procedure

4	Therapeutics 11/2013 - 01/2006
2	Immunotherapy 01/2020 - 01/2005
1	Transplantation 01/2014
1	Stem Cell Transplantation 01/2014